Proton pump inhibitor effect: Difference between revisions
Jump to navigation
Jump to search
| Line 51: | Line 51: | ||
==See also== | ==See also== | ||
*[[Stomach]]. | *[[Stomach]]. | ||
*[[Glycogenic acanthosis of the esophagus]]. | |||
==References== | ==References== | ||
Revision as of 10:18, 16 May 2015
Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.
Formally, it is stomach with proton pump inhibitor effect.
General
- Due to intake of a proton pump inhibitor (PPI).
- Used to treat gastroesophageal reflux disease.
Some proton pump inhibitors
| Generic name | Brand name(s) |
|---|---|
| Omeprazole | LOSEC |
| Dexlansoprazole | DEXILANT |
| Lansoprazole | PREVACID |
| Esomeprazole | NEXIUM |
| Pantoprazole | PANTOLOC |
| Rabeprazole | PARIET |
Microscopic
Features:[1]
- Parietal cell enlargement - key feature.
- Parietal cells typically bulge into the lumen.
Images
-
PPI effect - intermed. mag. -
PPI effect - high mag. -
PPI effect - very high mag.
www:
Sign out
- Usually not reported.